Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("TAGAWA, Scott T")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 24 of 24

  • Page / 1
Export

Selection :

  • and

A phase II study of the efficacy and safety of AMG 102 in patients with metastatic renal cell carcinomaSCHÖFFSKI, Patrick; GARCIA, Jorge A; MIN ZHU et al.BJU international (Papier). 2011, Vol 108, Num 5, pp 679-686, issn 1464-4096, 8 p.Article

Survival analysis after resection of metastatic disease followed by peptide vaccines in patients with stage IV melanomaTAGAWA, Scott T; CHEUNG, Eric; BANTA, Warren et al.Cancer. 2006, Vol 106, Num 6, pp 1353-1357, issn 0008-543X, 5 p.Article

Pathologic Nodal Staging Score for Bladder Cancer: A Decision Tool for Adjuvant Therapy After Radical CystectomySHARIAT, Shahrokh F; RINK, Michael; NOVARA, Giacomo et al.European urology. 2013, Vol 63, Num 2, pp 371-378, issn 0302-2838, 8 p.Article

Randomized phase II study of danusertib in patients with metastatic castration-resistant prostate cancer after docetaxel failureMEULENBELD, Hielke J; BLEUSE, Jean P; STERNBERG, Cora N et al.BJU international (Papier). 2013, Vol 111, Num 1, pp 44-52, issn 1464-4096, 9 p.Article

Sequential Sorafenib and Sunitinib for Renal Cell CarcinomaSABLIN, M. P; NEGRIER, S; RAVAUD, A et al.The Journal of urology. 2009, Vol 182, Num 1, pp 29-34, issn 0022-5347, 6 p.Article

Targeted Next-generation Sequencing of Advanced Prostate Cancer Identifies Potential Therapeutic Targets and Disease HeterogeneityBELTRAN, Himisha; YELENSKY, Roman; STEPHENS, Philip J et al.European urology. 2013, Vol 63, Num 5, pp 920-926, issn 0302-2838, 7 p.Article

New Therapies for Castration-Resistant Prostate Cancer: Efficacy and SafetyBELTRAN, Himisha; BEER, Tomasz M; TANNOCK, Ian F et al.European urology. 2011, Vol 60, Num 2, pp 279-290, issn 0302-2838, 12 p.Article

Anti-Prostate-Specific Membrane Antigen-Based Radioimmunotherapy for Prostate CancerTAGAWA, Scott T; BELTRAN, Himisha; VALLABHAJOSULA, Shankar et al.Cancer. 2010, Vol 116, Num 4, pp 1075-1083, issn 0008-543X, 9 p., SUPConference Paper

Subclinical haemostatic activation and current surgeon volume predict bleeding with open radical retropubic prostatectomyTAGAWA, Scott T; DORFF, Tanya B; ROCHANDA, Leanne et al.BJU international (Papier). 2008, Vol 102, Num 9, pp 1086-1091, issn 1464-4096, 6 p.Article

Carboplatin plus paclitaxel therapy after docetaxel in men with metastatic castrate resistant prostate cancerJESKE, Stephanie; TAGAWA, Scott T; OLOWOKURE, Olugbenga et al.Urologic oncology. 2011, Vol 29, Num 6, pp 676-681, issn 1078-1439, 6 p.Article

Predictors of survival in patients with disease recurrence after radical nephroureterectomyKLUTH, Luis A; XYLINAS, Evanguelos; FRITSCHE, Hans-Martin et al.BJU international (Papier). 2014, Vol 113, Num 6, pp 911-917, issn 1464-4096, 7 p.Article

Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomyRINK, Michael; HANSEN, Jens; KARAKIEWICZ, Pierre I et al.BJU international (Papier). 2013, Vol 111, Num 1, pp 74-84, issn 1464-4096, 11 p.Article

Phase II Study of Lutetium-177―Labeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Metastatic Castration-Resistant Prostate CancerTAGAWA, Scott T; MILOWSKY, Matthew I; SCHER, Howard I et al.Clinical cancer research (Print). 2013, Vol 19, Num 18, pp 5182-5191, issn 1078-0432, 10 p.Article

Tolerability, safety and pharmacokinetics of ridaforolimus in combination with bicalutamide in patients with asymptomatic, metastatic castration-resistant prostate cancer (CRPC)MEULENBELD, Hielke J; DE BONO, Johann S; TAGAWA, Scott T et al.Cancer chemotherapy and pharmacology. 2013, Vol 72, Num 4, pp 909-916, issn 0344-5704, 8 p.Article

Adjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma: Results From the Upper Tract Urothelial Carcinoma CollaborationHELLENTHAL, Nicholas J; SHARIAT, Shahrokh F; NG, Casey K et al.The Journal of urology. 2009, Vol 182, Num 3, pp 900-906, issn 0022-5347, 7 p.Article

Double-Blind, Randomized, Phase 2 Trial of Maintenance Sunitinib Versus Placebo After Response to Chemotherapy in Patients With Advanced Urothelial CarcinomaGRIVAS, Petros D; DAIGNAULT, Stephanie; WONG, Steven G et al.Cancer. 2014, Vol 120, Num 5, pp 692-701, issn 0008-543X, 10 p.Article

Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy?RINK, Michael; SHARIAT, Shahrokh F; TAGAWA, Scott T et al.World journal of urology (Print). 2012, Vol 30, Num 6, pp 807-814, issn 0724-4983, 8 p.Article

Taxane-Induced Blockade to Nuclear Accumulation of the Androgen Receptor Predicts Clinical Responses in Metastatic Prostate CancerDARSHAN, Medha S; LOFTUS, Matthew S; BANDE, Neil H et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 18, pp 6019-6029, issn 0008-5472, 11 p.Article

Phase II Trial of Paclitaxel, Carboplatin and Gemcitabine in Patients With Locally Advanced Carcinoma of the Bladder. CommentarySMITH, David C; MACKLER, Niklas J; BEEKMAN, Kathleen et al.The Journal of urology. 2008, Vol 180, Num 6, pp 2384-2388, issn 0022-5347, 5 p.Article

Phase I study of intranodal delivery of a plasmid DNA vaccine for patients with Stage IV melanomaTAGAWA, Scott T; LEE, Peter; SNIVELY, Jolie et al.Cancer. 2003, Vol 98, Num 1, pp 144-154, issn 0008-543X, 11 p.Article

An Open-Label, Single-Arm, Phase 2 Trial of the Polo-Like Kinase Inhibitor Volasertib (BI 6727) in Patients With Locally Advanced or Metastatic Urothelial CancerSTADLER, Walter M; VAUGHN, David J; LEE, Peter et al.Cancer. 2014, Vol 120, Num 7, pp 976-982, issn 0008-543X, 7 p.Article

A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancerHUDES, Gary; TAGAWA, Scott T; WHANG, Young E et al.Investigational new drugs. 2013, Vol 31, Num 3, pp 669-676, issn 0167-6997, 8 p.Article

Extranodal Extension Is a Powerful Prognostic Factor in Bladder Cancer Patients with Lymph Node MetastasisFAJKOVIC, Harun; CHA, Eugene K; TAGAWA, Scott T et al.European urology. 2013, Vol 64, Num 5, pp 837-845, issn 0302-2838, 9 p.Article

Novel therapeutics for the management of castration-resistant prostate cancer (CRPC)LEE, Daniel J; CHA, Eugene K; DUBIN, Justin M et al.BJU international (Papier). 2012, Vol 109, Num 7, pp 968-985, issn 1464-4096, 18 p.Article

  • Page / 1